Open Access Open Access  Restricted Access Subscription Access

Objectives, Anatomy, Natural History, Histopathology, Complications, Deterrence and Patient Education of Cervical Squamous Cell Carcinoma

Srinivas G., Ramanjaneyulu D. V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, R. Faith Rani, P. Megha Varna

Abstract


After reviewing this article, participants shouldbe able to understand how to diagnose, treat, and post-treatment monitoring. This article explains about the natural history, epidemiology, clinical presentation, differential diagnosis, evaluation, treatment, complications, and prognosis of squamous cell cervical cancer. It also narrates the importance of patient education and healthcare teamwork in enhancing cervical cancer management outcomes.

 

Objectives

  • Recognize the pathologic processes that can result in the development of cervical cancer.
  • Estimate the differential diagnosis of cervical cancer.
  • Diagnose the treatment options available for the management of cervical cancer.
  • Communicate interprofessional team strategies for promoting care coordination for effective management of cervical cancer.

 


Full Text:

PDF

References


Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

Denny, L., Herrero, R., Levin, C., & Kim, J. J. (2015). Cervical cancer. In H. Gelband, P. Jha, R. Sankaranarayanan, & S. Horton (Eds.), Cancer: Disease control priorities (3rd ed., Vol. 3, pp. 421–435). The International Bank for Reconstruction and Development/The World Bank. https://doi.org/10.1596/978-1-4648-0340-3_ch22

Herbert, A., Holdsworth, G., & Kubba, A. (2010). Why young women should be screened for cervical cancer: The distinction between CIN2 and CIN3. International Journal of Cancer, 126(9), 2256–2257. https://doi.org/10.1002/ijc.25194

Beavis, A. L., Gravitt, P. E., & Rositch, A. F. (2017). Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer, 123(6), 1044–1050. https://doi.org/10.1002/cncr.30376

Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590

Brambs, C. E., Höhn, A. K., Hentschel, B., Fischer, U., Bilek, K., & Horn, L. C. (2019). The prognostic impact of grading in FIGO IB and IIB squamous cell cervical carcinomas. Geburtshilfe und Frauenheilkunde, 79(2), 198–204. https://doi.org/10.1055/a-0831-0507

Schlichte, M. J., & Guidry, J. (2015). Current cervical carcinoma screening guidelines. Journal of Clinical Medicine, 4(5), 918–932. https://doi.org/10.3390/jcm4050918

Malone, C., Barnabas, R. V., Buist, D. S. M., Tiro, J. A., & Winer, R. L. (2020). Cost-effectiveness studies of HPV self-sampling: A systematic review. Preventive Medicine, 132, 105953. https://doi.org/10.1016/j.ypmed.2020.105953

Madzima, T. R., Vahabi, M., & Lofters, A. (2017). Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review. Canadian Family Physician, 63(8), 597–601. https://pubmed.ncbi.nlm.nih.gov/28848489/

Petignat, P., Faltin, D. L., Bruchim, I., Tramèr, M. R., Franco, E. L., & Coutlée, F. (2007). Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecologic Oncology, 105(2), 530–535. https://doi.org/10.1016/j.ygyno.2007.02.006

Safaeian, M., Kiddugavu, M., Gravitt, P. E., Ssekasanvu, J., Murokora, D., Sklar, M., Serwadda, D., Wawer, M. J., Shah, K. V., & Gray, R. (2007). Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sexually Transmitted Diseases, 34(7), 429–436. https://doi.org/10.1097/01.olq.0000259117.22057.4f

Tropé, A., Sjøborg, K., Eskild, A., Cuschieri, K., Eriksen, T., Thoresen, S., Steinbakk, M., Laurak, V., Jonassen, C. M., Westerhagen, U., Jacobsen, M. B., Lie, A. K., & Jacobsen, M. B. (2009). Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. Journal of Clinical Microbiology, 47(8), 2458–2464. https://doi.org/10.1128/JCM.02112-08

Ting, J., Smith, J. S., & Myers, E. R. (2015). Cost-effectiveness of high-risk human papillomavirus testing with messenger RNA versus DNA under United States guidelines for cervical cancer screening. Journal of Lower Genital Tract Disease, 19(4), 333–339. https://doi.org/10.1097/LGT.0000000000000114

Cuzick, J., Sasieni, P., Davies, P., Adams, J., Normand, C., Frater, A., van Ballegooijen, M., & van den Akker-van Marle, E. (2000). A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: Summary and conclusions. British Journal of Cancer, 83(5), 561–565. https://doi.org/10.1054/bjoc.2000.1261

Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Dalla Palma, P., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., Naldoni, C., Pierotti, P., Rizzolo, R., Schincaglia, P., Zorzi, M., Zappa, M., Segnan, N., & Cuzick, J. (2010). Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial. Lancet Oncology, 11(3), 249–257. https://doi.org/10.1016/S1470-2045(09)70360-9


Refbacks

  • There are currently no refbacks.